 | Happy with Covaxin clinical trials: Belagavi doctor Dr Amit BhateThe vaccine has been given to over 26,000 people in the country. No side effects have been reported yet. |
 | Dummy mobile number, hospital address can be used for testing mentally ill homeless people: ICMR to HCICMR came out with the solution to address the issue of mentally ill homeless persons not being tested for COVID-19 for the lack of a government issued identity card. |
 | COVID-19: TN govt gives consent to BCG trial at ICMR's Chennai instituteHealth Minister C Vijayabaskar hoped that vaccinating the elderly with the time tested BCG would help reduce the intensity of COVID-19, admissions at hospitals and mortality rates. |
 | India 'pharmacy of the world', on fast-track mode to develop COVID-19 vaccine: ICMRDr Bhargava said --i.e. 60 per cent of the vaccines (like Rubella, measles, polio) supplied in the world, whether it be Africa, Europe, South East Asia or anywhere are of Indian origin. |
 | ICMR writes to WHO disagreeing with HCQ assessment, officials say international trial dosage four times higher than IndiaBuoyed by the preliminary success observed in the treatment of COVID-19 patients through these HCQ tablets, the Indian Council of Medical Research (ICMR) has written to the WHO. |
 | Centre to conduct serosurvey in 10 hotspot cities to track community transmission of coronavirusSources said that in the project, 50 serum samples will be collected from 10 randomly picked containment areas in every city. This will amount to the overall testing of 5,000 samples in these cities. |
 | ICMR comes up with fully indigenous diagnostic platform for COVID-19ICMR has now recommended the TrueNat COVID-19 test as a two-step test. |
 | Machines used for testing drug-resistant TB can be now used for confirming COVID-19 casesThe Indian Council of Medical Research (ICMR) had approved the use of TrueNat system for conducting coronavirus tests on April 10, while recommending it only as a screening test. |
 | ICMR, NCDC to start serosurvey to monitor COVID-19 prevalence at district levelThe Indian Council of Medical Research and the National Centre for Disease Control will collaborate with key stakeholders for the survey at 10 health facilities (6 public and 4 private). |
 | Rajasthan to start plasma therapy on COVID-19 patients from Monday: GehlotThe CM said the government will also start tele-medicines service from Monday so that people can get medical counselling and treatment sitting at home during the lockdown. |
 | ICMR tells states to stop using rapid antibody test kits procured from two Chinese firmsThe health ministry on its part issued a statement saying that after receipt of some supplies, ICMR has conducted quality checks on these kits in field conditions. |
 | IIT professor develops software to detect COVID-19 within five seconds using X-ray scanThe professor, who took over 40 days to develop the software, has filed a patent for the same and has approached the Indian Council of Medical Research (ICMR) for a review. |
 | 99 institutes willing to take part in clinical trial of plasma therapy for COVID-19 treatment: ICMRICMR added that each institute that wished to participate in the study would need to mandatorily obtain ethics clearance locally, through their Institutional Ethics Committee. |
 | COVID-19: ICMR launches study on side effects of hydroxychloroquineHead of Epidemiology and Communicable diseases at ICMR Raman R Gangakhedkar said the ICMR has launched a study on side effects of HCQ using data of some healthcare workers. |
 | Central drug regulator permits clinical trial of convalescent plasma in COVID-19 patientsThe Drug Controller General of India said ICMR has submitted a list of institutes, which have shown an interest in the trial, to the Central Drugs Standard Control Organisation. |
